Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Avanir and OptiNose enter development and commercialization agreement

July 5, 2013

Purdue Pharma presents novel opioid receptor agonists and antagonists

July 5, 2013

Novel sodium channel blockers disclosed by Pfizer

July 4, 2013

Dr. Reddy's Laboratories patents new Trk-A inhibitors

July 4, 2013

TransTech Pharma meets with FDA for TTP-488

July 4, 2013

Lithium carbonate evaluated in phase II/III trial in Machado-Joseph disease

July 4, 2013

Novartis seeks approval of ELC-200 in Japan

July 3, 2013

New histamine H3 receptor antagonists disclosed by Taisho Pharmaceutical

July 3, 2013

NeuroMax signs license agreement with Aquilus Pharmaceuticals for AQU-005

July 3, 2013

FDA approves Latuda as monotherapy and adjunctive therapy for bipolar depression

July 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...